Publications by authors named "Mike Fischer"

Claim this Profile
V
Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy.
Ulf Schnetzke, Mike Fischer, Christoph Röllig, André Scherag, Heidi Altmann

Genes Immun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Effects of the RAR Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation.
Maximilian Fleischmann, Julia Bechwar, Diana Voigtländer, Mike Fischer, Ulf Schnetzke

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance.
Maximilian Fleischmann, Mike Fischer, Ulf Schnetzke, Colin Fortner, Joanna Kirkpatrick

Cells· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymethine Dye-Functionalized Nanoparticles for Targeting CML Stem Cells.
Philipp Ernst, Adrian T Press, Mike Fischer, Vivien Günther, Christine Gräfe

Mol Ther Oncolytics· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell cycle-dependent and -independent telomere shortening accompanies murine brain aging.
Quratul Ain, Christian Schmeer, Diane Penndorf, Mike Fischer, Tzvetanka Bondeva

Aging (Albany NY)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity.
Mike Fischer, Jörg P Müller, Bärbel Spies-Weisshart, Christine Gräfe, Oliver Kurzai

Eur J Immunol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of FLT3-ITD diversity on response to induction chemotherapy in patients with acute myeloid leukemia.
Mike Fischer, Ulf Schnetzke, Bärbel Spies-Weisshart, Mario Walther, Maximilian Fleischmann

Haematologica· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia.
Mike Fischer, Baerbel Spies-Weisshart, Karin Schrenk, Bernd Gruhn, Susan Wittig

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical MAPK-activation in response to treatment with tyrosine kinase inhibitors in CML: flow cytometry loses track.
Ulf Schnetzke, Mike Fischer, Jochen J Frietsch, Andreas Finkensieper, Joachim H Clement

Cytometry B Clin Cytom· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells.
Ulf Schnetzke, Mike Fischer, Bärbel Spies-Weisshart, Elisabeth Zirm, Andreas Hochhaus

Leuk Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells.
Ulf Schnetzke, Mike Fischer, Anne-Kathrin Kuhn, Bärbel Spies-Weisshart, Elisabeth Zirm

J Cancer Res Clin Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.
Edit Kovalcsik, Katie Lowe, Mike Fischer, Angus Dalgleish, Mark D Bodman-Smith

Cancer Immunol Immunother· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis